InvestorsHub Logo
Post# of 317216
Next 10
Followers 365
Posts 114067
Boards Moderated 5
Alias Born 12/28/2000

Re: None

Tuesday, 02/27/2024 9:52:48 AM

Tuesday, February 27, 2024 9:52:48 AM

Post# of 317216
NERV down 57% FDA has rejected the company's application seeking approval of lead drug candidate roluperidone
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.